References
- [1] Abrams P, Kelleher C, Staskin D et al. Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Doseranging, Phase 2 Study (Symphony). Eur Urol. 2015;67:577-588.
- [2] Andersson KE. Drug therapy of overactive bladder – What is comming next? Korean J. Urol. 2015;56:673-679.
- [3] Cernecka H, Kersten K, Maarsingh H et al. β3-Adrenoceptormediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase. Naunyn Schmiedebergs Arch. Pharmacol. 2015;388:749–759.
- [4] DeHaven WI, Smyth JT, Boyles RR, et al. Complex Actions of 2-Aminoethyldiphenyl Borate on Store-operated Calcium Entry. J Biol Chem. 2008; 283:19265
- [5] Feske S, Gwack Y, Prakriya M et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2016;441:179–185.
- [6] Fox J, Weisberg S. An R Companion to Applied Regression, Second Edition. Thousand Oaks CA: Sage. 2011
- [7] Franova S, Janicek F, Visnovsky J et al. Utero-relaxant effect of PDE4-selective inhibitor alone and in simultaneous administration with β2-mimetic on oxytocin-induced contractions in pregnant myometrium. Int J Gynaecol Obstet. 2009;35:20-25.
- [8] Gormley EA, Lightner DJ, Faraday M, Vasavada SP. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment. J Urol. 2015;193:1-9.
- [9] Hedge SS. Muscarinic receptors in the bladder: from basic research to therapeutics. Br. J. Pharmacol. 2006; 147:S80-S87.
- [10] Hill-Eubanks DC, Werner ME, Heppner TJ, Nelson MT. Calcium Signaling in Smooth Muscle. Cold Spring Harb. Perspect. Biol. 2011;3:a004549.
- [11] Maman K, Aballea S, Nazir J et al. Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison. Eur Urol. 2014;65:755-765.
- [12] Mair P, Schoenbrodt F, Wilcox R. WRS2: Wilcox robust estimation and testing. 2016
- [13] Parajuli SP, Zheng YM, Levin R, Wang YX. Big-conductance Ca2+- activated K+ channels in physiological and pathophysiological urinary bladder smooth muscle cells. Channels. 2016;10:355-364.
- [14] R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, https://www.R-project.org/. 2015
- [15] Rajalabaya R, Leen G, Chellian J, Chakravarthi S, David SR. Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder. Pharmaceutics. 2016;8:27.
- [16] Sharaf A, Hashim H. Profile of mirabegron in the treatment of overactive bladder: place in therapy. Drug Des Devel Ther. 2017;11:463–467.
- [17] Sui GP, Wu C, Severs N, Newgreen D, Fry CH. The association between T-type Ca2+ current and outward current in isolated human detrusor cells from stable and overactive bladders. BJU International. 2007;99:436–441.
- [18] Sutovska M., Nosalova G., Franova S. The role of potassium ion channels in cough and other reflexes of the airways. J Physiol Pharmacol. 2007;58:673-683.
- [19] Tanahashi Y, Wang B, Murakami Y et al.. Inhibitory effects of SKF96365 on the activities of K+ channels in mouse small intestinal smooth muscle cells. J. Vet. Med. Sci. 2016;78(2):203-211.
- [20] Zhao B, Zhong X, Bai X, Wang Q, Song B, Li L. Changes in storeoperated calcium channels in rat bladders with detrusor overactivity. Urology. 2014;84:491.e1-6.